Source: Nasdaq

Neurocrine Biosciences: Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential

Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Kyle W. Gano's photo - CEO of Neurocrine Biosciences

CEO

Kyle W. Gano

CEO Approval Rating

85/100

Read more